Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
Department of Pathology and Anatomical Sciences and Program for Neuroscience, School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY, USA.
Tracey A
TA
Ignatowski
Robert N
RN
Spengler
Edward
E
Tobinick
D000818:Animals; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D020521:Stroke / Q000150:complications* / Q000188:drug therapy*
D007074:Immunoglobulin G; D018696:Neuroprotective Agents; D018124:Receptors, Tumor Necrosis Factor